BGIM
ATRS

Brandywine Global Investment Management’s Antares Pharma, Inc. ATRS Stock Holding History

Brandywine Global Investment Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,310,817
Closed -$5.37M – 785
2022
Q1 		$5.37M Sell
1,310,817
-436
-0% -$1.58K 0.04% 376
2021
Q4 		$4.68M Buy
1,311,253
+1,030,664
+367% +$3.6M 0.03% 417
2021
Q3 		$1.02M Sell
280,589
-2,864
-1% -$11.6K 0.01% 572
2021
Q2 		$1.24M Sell
283,453
-18,029
-6% -$73.4K 0.01% 568
2021
Q1 		$1.24M Sell
301,482
-2,735
-0.9% -$11.9K 0.01% 550
2020
Q4 		$1.21M Sell
304,217
-18,176
-6% -$58.8K 0.01% 520
2020
Q3 		$871K Buy
322,393
+33,770
+12% +$93.5K 0.01% 504
2020
Q2 		$794K Buy
288,623
+2,535
+0.9% +$7.07K 0.01% 520
2020
Q1 		$676K Buy
+286,088
New +$973K 0.01% 537

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Brandywine Global Investment Management's ATRS Position: Q2 2022 in Review

Brandywine Global Investment Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 1,310,817 shares — an estimated $5.37M sold.

Brandywine Global Investment Management first reported a position in ATRS in Q1 2020 and held it in 9 quarters. The position peaked at $5.37M in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Brandywine Global Investment Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Brandywine Global Investment Management sold 1,310,817 Antares Pharma, Inc. shares in Q2 2022, an estimated $5.37M.
  • Brandywine Global Investment Management first reported a position in Antares Pharma, Inc. in Q1 2020 and held it in 9 quarters.
  • Brandywine Global Investment Management's Antares Pharma, Inc. position peaked at $5.37M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Brandywine Global Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.